0.0130
+0.0040
+(44.44%)
At close: January 23 at 7:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-279.6270
-106.7650
-656.6200
-235.4820
-14.2530
Investing Cash Flow
--
--
--
-2.7460
--
Financing Cash Flow
165.0000
--
-225.0000
1,395.0000
125.0000
End Cash Position
202.3580
279.1340
385.8990
1,267.5190
110.7470
Interest Paid Supplemental Data
--
--
17.5420
--
--
Capital Expenditure
--
--
--
-2.7460
--
Issuance of Capital Stock
--
--
150.0000
--
--
Issuance of Debt
165.0000
--
250.0000
1,395.0000
125.0000
Repayment of Debt
--
--
-625.0000
--
--
Free Cash Flow
-279.6270
-106.7650
-656.6200
-238.2280
-14.2530
12/31/2020 - 3/31/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRZM Marizyme, Inc.
0.0500
0.00%
MRES Institute of Biomedical Research Corp.
0.0211
-20.41%
NRXPW NRx Pharmaceuticals, Inc.
0.1800
-10.00%
MBIO.CN MindBio Therapeutics Corp.
0.0250
0.00%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
GTBP GT Biopharma, Inc.
2.4200
+1.68%
DBVT DBV Technologies S.A.
4.3400
-1.36%
CYCC Cyclacel Pharmaceuticals, Inc.
0.3710
+6.00%
PHGE BiomX Inc.
0.8200
+2.50%
THTX Theratechnologies Inc.
1.7150
-0.29%